Identification of short peptides: optimization of target therapeutic properties of the thymus medicine


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. The identification of molecular components contributes to the realization of the targeted properties of multicomponent drugs to study their molecular mechanism and therapeutic targets. The polypeptide complex isolated from cattle thymus (thymalin), and short peptides KE (Lys-Glu), EDP (Glu-Asp-Pro), designed and then synthesized based on the analysis of its amino acid composition, have similar biological effects. The dipeptide EW was previously found in the thymalin medicine. The aim of the study. Identification of short peptides KE and EDP as part of the thymus polypeptide complex. Method. In order to confirm the presence of these peptides in thymalin, the method of ultra-efficient liquid chromatography-mass spectrometry was used. Results. As a result of the study, the short peptides KE and EDP were found to be a part (minor components) of the thymus polypeptide complex (thymalin). Conclusion. The biological and therapeutic activity of the thymalin medicine is due to the effects of the short peptides KE and EDP found in this study, and the dipeptide EW, which was previously discovered in its composition.

Full Text

Restricted Access

About the authors

Vladimir Khatskelevich Khavinson

St. Petersburg Institute of Bioregulation and Gerontology; Pavlov Institute of Physiology

Email: secretary@gerontology.ru
Director

Inna Konstantinovna Zhurkovich

Institute of Toxicology, Federal Medico-Biological Agency

Email: zhurkovich.i.k@toxicology.ru
Head of the Laboratory of Toxicological Chemistry of Organic Compounds.

Galina Anatolievna Ryzhak

St. Petersburg Institute of Bioregulation and Gerontology

Email: secretary@gerontology.ru
Deputy Director for Research and New Technologies.

Ekaterina Sergeevna Mironova

St. Petersburg Institute of Bioregulation and Gerontology

Email: katerina.mironova@gerontology.ru
Researcher, Laboratory of Molecular Mechanisms of Aging, Department of Biogerontology.

Nikolay Grigorievich Kovrov

Institute of Toxicology, Federal Medico-Biological Agency

Email: kovrovn@mail.ru
Chemical engineer

References

  1. Хавинсон В.Х., Копылов А.Т., Васьковский Б.В., Рыжак ГА., Линькова Н.С. Идентификация пептида AEDG в полипептидном комплексе эпифиза. Бюллетень экспериментальной биологии и медицины. 2017; 164 (7): 52-5
  2. Журкович И.К., Ковров Н.Г, Рыжак Г.А., Миронова Е.С., Хавинсон В.Х. Идентификация коротких пептидов в составе полипептидных комплексов, выделенных из органов животных. Успехи современной биологии. 2020; 140 (2): 140-8. https://doi.org/10.31857/S004213242002012X
  3. Хавинсон В.Х., Кузник Б.И., Рыжак Г.А. Пептидные геропротекторы - эпигенетические регуляторы физиологических функций организма. СПб.: РГПУ им. А.И. Герцена, 2014; 271
  4. Anisimov V.N., Khavinson V.Kh. Peptide bioregulation of aging: results and prospects. Biogerontology 2010; 11 (2): 139-49.
  5. Khavinson V.Kh., Morozov, V.G. Peptides of pineal gland and thymus prolong human life. Neuroendocrinology Letters. 2003; 24 (3/4): 233-40.
  6. Смирнов В.С., Зарубаев В.В., Петленко С.В. Биология возбудителей и контроль гриппа и ОРВИ. СПб.: Гиппократ, 2020
  7. Zhukova G.V., Schikhlyarova A.I., Barteneva T.A., Shevchenko A.N., Zakharyuta F.M. Effect of thymalin on the tumor and thymus under conditions of activation therapy in vivo. Bull Exp. Biol. Med. 2018; 165 (1): 80-3. https://doi.org/10.1007/s10517-018-4104-z
  8. Долина А.Б., Кузник Б.И., Розенберг В.Я., Вишнякова Т.М., Витковский Ю.А. Влияние тималина на состояние иммунитета и лимфоцитарно-тромбоцитарную адгезию у детей с вторичным инфекционным эндокардитом. Медицинская иммунология. 2010; 12 (4-5): 381-6
  9. Khlystova ZS, Kalinina II, Shmeleva SP Thymalin in developing respiratory organs of human fetus. Bull Exp. Biol. Med. 2003; 135 (6): 600-2. https://doi.org/10.1023/a:1025449923475
  10. Кузник Б.И., Витковский Ю.А., Будажабон Г.Б., Сизоненко В.А. Влияние тималина на свертываемость крови и содержание провоспалительных и противовоспалительных цитокинов у больных с ожоговой болезнью. Вестник хирургии им. И.И. Грекова. 2000; 159 (5): 39-43
  11. Silin D.S., Lyubomska O.V., Ershov F.I., Frolov V.M., Kutsyna G.A. Synthetic and natural immunomodulators acting as interferon inducers. Curr Pharm Des. 2009; 15 (11): 1238-47. https://doi.org/10.2174/138161209787846847.
  12. Smirnov VS., Petlenko S.V, El'tsin S.S. Application thymogen for preoperative preparation of elderly patients with tumor processes in abdominal cavity. Adv Gerontol. 2011; 24 (2): 278-84.
  13. Khavinson V.Kh., Malinin V.V. Gerontological Aspects of Genome Peptide Regulation, Basel (Switzerland): Karger AG. 2005; 104.
  14. Kolchina N., Khavinson V, Linkova N., Yakimov A., Baitin D., Afanasyeva A., Petukhov M. Systematic search for structural motifs of peptide binding to double-stranded DNA. Nucleic Acids Research. 2019; 47 (20): 10553-63. https://doi.org/10.1093/narlgkz850
  15. Solovyev A.Y., Tarnovskaya S.I., Chernova I.A., Shataeva L.K., Skorik Y.A. The interaction of amino acids, peptides, and proteins with DNA. Int. J. Biol. Macromol. 2015; 78: 39-45. https://doi.org/10.1016/j.ijbio-mac.2015.03.054.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Russkiy Vrach Publishing House